Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma

Stopped early · Phase 2

Conditions studied: Brain Cancer

In brief

This pilot phase II trial studies how well giving temozolomide, bevacizumab, lithium carbonate, and radiation therapy works in treating patients with newly diagnosed high grade glioma.

Key facts

Study ID

NCT01105702

Run by

NYU Langone Health

People needed

28

Starts

2010-05-01

Expected to finish

2015-04-01

Last updated by the study team

2016-08-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Newly diagnosed high grade glioma (WHO Grade III and IV)
• Brain magnetic resonance imaging (MRI) scan with gadolinium contrast
• Patient must have normal organ and marrow function as defined below:
• Absolute neutrophil count >= 1,500/mm\^3;
• Platelet count >=100,000/mm\^3;
• Hemoglobin >= 10g/dL;
• Blood urea nitrogen and serum creatinine both =< 1.5 times upper limit of normal (ULN);
• Total bilirubin both =< 1.5 times ULN;
• SGOT and SGPT both =< 3 times ULN;
• Alkaline phosphatase =< 2 times ULN.
• >=18 years of age;
• Karnofsky Performance Score >= 70;
• Life expectancy >= 8 weeks;
• Negative serum or urine beta-hCG pregnancy test at screening for patients of child bearing potential;
• Men and women with reproductive potential must agree to use an acceptable method of birth control (surgical, hormonal or double barrier, ie, condom and diaphragm) during treatment and for 6 months after completion of treatment;
• Patient or their legal proxy must provide written informed consent prior to registration on study;
• Residual measurable disease.

You may not qualify if…

• Current, recent (within 4 weeks of the first infusion of this study), or planned participation in an experimental drug study;
• Prior radiation therapy to the brain;
• Prior treatment with Chemotherapy or Targeted agent
• Previous (within last 5 years) or current malignancies at other sites except for adequately treated basal cell or squamous cell skin cancer in situ carcinoma of the cervix;
• (Uncontrolled High blood pressure >150/100
• Common Terminology Criteria Adverse Event 3.0 >= Grade 2 congestive heart failure (CHF);
• History of myocardial infarction within 6 months;
• History of stroke within 6 months;
• Clinically significant peripheral vascular disease;
• Evidence of bleeding diathesis or coagulopathy;
• Major surgical procedure, open biopsy, or significant traumatic injury within 28 days prior to the first dose of bevacizumab or anticipation of need for major surgical procedure during the course of the study;
• Minor surgical procedures, fine needle aspirations or core biopsies within 7 days prior to study enrollment;
• Urine protein/Creatinine ratio >= 2.0 at screening;
• Serious, non-healing wound, ulcer, or bone fracture;
• Inability to comply with study and/or follow-up procedures;
• Glioma showing active intratumoral bleeding;
• Patients on enzyme-inducing anti-epileptic drugs;
• Known Positive HIV-1, hepatitis B surface antigen, or hepatitis C antibody;
• Medications like nonsteroidal antiinflammatory drugs, antipsychotics, iodides, and angiotensin-converting enzyme inhibitor, If they are receiving them, they must have been discontinued for 7 days prior to initiating lithium;
• Any previous cytotoxic drug therapies, excluding corticosteroids and temozolomide concurrent with radiation therapy;
• Any known genetic cancer-susceptibility syndromes;
• Acute infection: any active viral, bacterial, or fungal infection that requires specific therapy.
• Active uncontrolled infection - examples include sexually transmitted disease, herpes, scrofula, malaria, etc.;
• Fever > 101.5 degrees Fahrenheit;
• Unstable or severe intercurrent medical conditions such as unstable angina, uncontrolled arrythmias, Crohn's disease, ulcerative colitis, psoriasis, etc.;

Where it is running

• Overlook Hospital — Summit, New Jersey, United States
• New York University Clinical Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.